Laura Esserman, M.D., M.B.A., is the director of the Carol Franc Buck Breast Care Center and co-leader of the Breast Oncology Program of the UCSF Helen Diller Family Comprehensive Cancer Center. She is one of America’s leading experts in breast cancer research and treatment. Her work spans the spectrum from basic science to public policy issues and the impact of both on the delivery of clinical care. Esserman is professor of surgery and radiology at UCSF and director of the UCSF Carol Franc Buck Breast Care Center. She is a leader of the innovative I-SPY TRIAL model, designed to accelerate the identification and approval of effective new agents for women with high risk breast cancers. The goal of the I-SPY TRIAL model is to shave several years and tens of millions of dollars off the drug-development process, a paradigm now being developed for use in other disease domains.
Sessions as a Speaker
Flagship Lunch @ UCSF: Provocative issues in cancer — immunotherapy, when not to treat, global cancer burden
- UCSF Mission Bay Campus